Leading account and intent-based sales and marketing providers and technology solutions for the clinical trials industry: Introduction In the complex field …
AC Immune’s stock price has jumped by more than 20% after all patients in a trial of its Parkinson’s disease …
Tivic Health has completed enrolment in a study being conducted to finetune its non-invasive vagus nerve stimulation (VNS) device that …
Spirovant Sciences has announced the commencement of its SAAVe Phase I/II study, with the first patient receiving a dose of …
The city of Munich is set to play host to the 11th annual Clinical Trials in Oncology Europe 2024 conference …
The city of Munich is set to play host to the 11th annual Clinical Trials in Oncology Europe 2024 conference …
Exact Sciences has unveiled new findings from a case-control study demonstrating the potential of its advanced multi-biomarker class approach to …
Johnson & Johnson (J&J) has reported promising results from the Phase II DAHLIAS study of nipocalimab, a neonatal crystallisable fragment …
GSK has announced positive headline interim analysis outcomes from a Phase III trial, which is evaluating Blenrep (belantamab mafodotin) along …
President-elect Donald Trump has appointed Robert F Kennedy Jr, popularly known as RFK Jr, as the secretary of the premier …
Xeltis has hit two milestones for its vascular access conduit, with one coming in the regulatory arena and the other …
Adaptimmune’s pivotal Phase II trial of its investigational T cell therapy lete-cel has met its primary endpoint, with the company …
Microbion has reported positive topline results from its Phase II study of pravibismane, a topical treatment for diabetic foot ulcer …
Paratek Pharmaceuticals has announced positive top-line safety, efficacy, and tolerability data from a Phase IIb study of oral omadacycline. In …
Amgen has spoken out about concerns related to bone mineral density (BMD) loss with its obesity candidate after an analyst’s …
